litlas
ログインアカウント作成

Thomas Kissel

1991–2020 年に発表

121
論文数
24,584
被引用数
96
h 指数
121
i10 指数

被引用数

Thomas Kissel の年別被引用数1992 年: 被引用 2 件1993 年: 被引用 9 件1994 年: 被引用 8 件1995 年: 被引用 18 件1996 年: 被引用 25 件1997 年: 被引用 21 件1998 年: 被引用 47 件1999 年: 被引用 44 件2000 年: 被引用 59 件2001 年: 被引用 66 件2002 年: 被引用 77 件2003 年: 被引用 138 件2004 年: 被引用 179 件2005 年: 被引用 237 件2006 年: 被引用 284 件2007 年: 被引用 312 件2008 年: 被引用 366 件2009 年: 被引用 398 件2010 年: 被引用 393 件2011 年: 被引用 419 件2012 年: 被引用 331 件2013 年: 被引用 288 件2014 年: 被引用 297 件2015 年: 被引用 264 件2016 年: 被引用 232 件2017 年: 被引用 164 件2018 年: 被引用 159 件2019 年: 被引用 504 件2020 年: 被引用 456 件2021 年: 被引用 460 件2022 年: 被引用 312 件2023 年: 被引用 217 件2024 年: 被引用 298 件2025 年: 被引用 136 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,430 件、この内訳の 19.8%中国: 引用元論文 1,035 件、この内訳の 14.3%ドイツ: 引用元論文 502 件、この内訳の 7%インド: 引用元論文 403 件、この内訳の 5.6%イギリス: 引用元論文 296 件、この内訳の 4.1%韓国: 引用元論文 285 件、この内訳の 3.9%フランス: 引用元論文 193 件、この内訳の 2.7%カナダ: 引用元論文 188 件、この内訳の 2.6%日本: 引用元論文 177 件、この内訳の 2.5%イラン: 引用元論文 175 件、この内訳の 2.4%イタリア: 引用元論文 167 件、この内訳の 2.3%スペイン: 引用元論文 164 件、この内訳の 2.3%
0%19.8%その他 30.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology36.1%
  • Materials Science20.7%
  • Pharmacology, Toxicology and Pharmaceutics15.9%
  • Medicine14.3%
  • Engineering4.6%
  • Immunology and Microbiology2.8%
  • その他5.6%

トピック

  • RNA Interference and Gene Delivery13.6%
  • Advanced Drug Delivery Systems8.9%
  • Advanced biosensing and bioanalysis techniques8.1%
  • Nanoparticle-Based Drug Delivery7.1%
  • Virus-based gene therapy research3%
  • Drug Solubulity and Delivery Systems2.9%
  • その他56.4%

共著者

全論文

検索で開く
  1. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis

    著者: Dagmar Fischer, Youxin Li, Barbara Ahlemeyer, Josef Krieglstein, Thomas Kissel - Biomaterials 2003 被引用: 2,303

  2. Chitosan-based formulations for delivery of DNA and siRNA

    著者: Shirui Mao, Wei Sun, Thomas Kissel - Advanced Drug Delivery Reviews 2009 被引用: 953

  3. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

    著者: Michael Neu, Dagmar Fischer, Thomas Kissel - The Journal of Gene Medicine 2005 被引用: 862

  4. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection

    著者: Jens Lipka, Manuela Semmler‐Behnke, Ralph A. Sperling, Alexander Wenk, Shinji Takenaka, Carsten Schleh, Thomas Kissel, Wolfgang J. Parak, Wolfgang G. Kreyling - Biomaterials 2010 被引用: 527

  5. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres

    著者: S MAO, Jie Xu, Changhong Cai, Oliver Germershaus, Andreas Schaper, Thomas Kissel - International Journal of Pharmaceutics 2006 被引用: 273

  6. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

    著者: Lea Ann Dailey, Thomas Schmehl, Tobias Gessler, Matthias Wittmar, Friedrich Grimminger, Werner Seeger, Thomas Kissel - Journal of Controlled Release 2002 被引用: 177

  7. A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity

    著者: Dagmar Fischer, Thorsten Bieber, Youxin Li, Hans‐Peter Elsässer, Thomas Kissel - Pharmaceutical Research 1999 被引用: 1,208

  8. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

    著者: Ana Vila, Alejandro Sánchez, Kevin A. Janes, Isabel Behrens, Thomas Kissel, José Luis Vila Jato, Marı́a José Alonso - European Journal of Pharmaceutics and Biopharmaceutics 2003 被引用: 446

  9. In situ forming parenteral drug delivery systems: an overview

    著者: Claudia B. Packhaeuser, Julia Schnieders, Christine G. Oster, Thomas Kissel - European Journal of Pharmaceutics and Biopharmaceutics 2004 被引用: 409

  10. Biodegradable polymeric nanocarriers for pulmonary drug delivery

    著者: Erik Rytting, Juliane Nguyen, Xiaoying Wang, Thomas Kissel - Expert Opinion on Drug Delivery 2008 被引用: 264

  11. Controlled pulmonary drug and gene delivery using polymeric nano-carriers

    著者: Moritz Beck‐Broichsitter, Olivia M. Merkel, Thomas Kissel - Journal of Controlled Release 2011 被引用: 200

  12. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer

    著者: Thomas Merdan, Jindřich Kopeček, Thomas Kissel - Advanced Drug Delivery Reviews 2002 被引用: 782

  13. Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells

    著者: Isabel Behrens, Patric Stenberg, Per Artursson, Thomas Kissel - Pharmaceutical Research 2001 被引用: 219

  14. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method

    著者: Shirui Mao, Yi Shi, Luk Li, Jing Xu, Andreas Schaper, Thomas Kissel - European Journal of Pharmaceutics and Biopharmaceutics 2007 被引用: 162

  15. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro

    著者: Moritz Beck‐Broichsitter, Clemens Ruppert, Thomas Schmehl, Andreas Guenther, Thomas Betz, Udo Bakowsky, Werner Seeger, Thomas Kissel, Tobias Gessler - Nanomedicine Nanotechnology Biology and Medicine 2010 被引用: 116

  16. Nonviral Pulmonary Delivery of siRNA

    著者: Olivia M. Merkel, Thomas Kissel - Accounts of Chemical Research 2011 被引用: 101

  17. Nonviral siRNA Delivery to the Lung: Investigation of PEG−PEI Polyplexes and Their In Vivo Performance

    著者: Olivia M. Merkel, Andrea Beyerle, Damiano Librizzi, Andreas Pfestroff, Thomas M. Behr, Brian S. Sproat, Peter Barth, Thomas Kissel - Molecular Pharmaceutics 2009 被引用: 187

  18. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers

    著者: Olivia M. Merkel, Rudolf Urbanics, Péter Bedöcs, Zoltán Rozsnyay, László Rosivall, Miklós Tóth, Thomas Kissel, János Szebeni - Biomaterials 2011 被引用: 133

  19. siRNA Delivery to the lung: What's new?

    著者: Olivia M. Merkel, Israel Rubinstein, Thomas Kissel - Advanced Drug Delivery Reviews 2014 被引用: 132

  20. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model

    著者: Moritz Beck‐Broichsitter, Julia Gauss, Claudia B. Packhaeuser, Kerstin Lahnstein, Thomas Schmehl, Werner Seeger, Thomas Kissel, Tobias Gessler - International Journal of Pharmaceutics 2008 被引用: 115

  21. Polymer-related off-target effects in non-viral siRNA delivery

    著者: Olivia M. Merkel, Andrea Beyerle, Benedikt M. Beckmann, Mengyao Zheng, Roland K. Hartmann, Tobias Stöger, Thomas Kissel - Biomaterials 2010 被引用: 104

  22. Iloprost-Containing Liposomes for Aerosol Application in Pulmonary Arterial Hypertension: Formulation Aspects and Stability

    著者: Elke Kleemann, Thomas Schmehl, Tobias Gessler, Udo Bakowsky, Thomas Kissel, Werner Seeger - Pharmaceutical Research 2006 被引用: 83

  23. Characterization of commercially available and synthesized polyethylenimines for gene delivery

    著者: Anke von Harpe, Holger Petersen, Youxin Li, Thomas Kissel - Journal of Controlled Release 2000 被引用: 510

  24. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats

    著者: Marianne Roser, Dagmar Fischer, Thomas Kissel - European Journal of Pharmaceutics and Biopharmaceutics 1998 被引用: 352